BBUC vs GOF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BBUC exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating significant deterioration in fundamental performance. The negative Price/Book ratio of -5.05 and uncalculable Altman Z-Score suggest severe balance sheet distress, likely due to negative equity. Despite a recent 1-year price return of +52.8%, this is disconnected from fundamentals, as the company reports a -13.93% profit margin, 3.52 Debt/Equity ratio, and -23.90% YoY revenue growth. Valuation metrics are largely unavailable, but the stock appears deeply impaired from a financial stability and profitability standpoint.
The fund exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe deterioration in fundamental health. While the current price of $11.36 sits slightly below the growth-based intrinsic value of $12.11, this marginal discount is offset by an unsustainable dividend payout ratio of 126.31%. Technical trends are purely bearish (0/100), and the 1-year price performance is negative. Overall, the high yield appears to be a value trap given the underlying health metrics and negative price momentum.
Compare Another Pair
Related Comparisons
BBUC vs GOF: Head-to-Head Comparison
This page compares Brookfield Business Corporation (BBUC) and Guggenheim Strategic Opportunities Fund (GOF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.